JP2018513832A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513832A5 JP2018513832A5 JP2017541855A JP2017541855A JP2018513832A5 JP 2018513832 A5 JP2018513832 A5 JP 2018513832A5 JP 2017541855 A JP2017541855 A JP 2017541855A JP 2017541855 A JP2017541855 A JP 2017541855A JP 2018513832 A5 JP2018513832 A5 JP 2018513832A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound according
- hydrogen
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C)N(C1C(*)C1)C(N=C(C1)C1*=C)=C Chemical compound C*(C)N(C1C(*)C1)C(N=C(C1)C1*=C)=C 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510157772 | 2015-04-03 | ||
| CN201510157772.0 | 2015-04-03 | ||
| PCT/CN2016/077519 WO2016155593A1 (zh) | 2015-04-03 | 2016-03-28 | 4'-硫代核苷的新型化合物及其制备方法、药物组合物和应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513832A JP2018513832A (ja) | 2018-05-31 |
| JP2018513832A5 true JP2018513832A5 (show.php) | 2019-03-28 |
| JP6769000B2 JP6769000B2 (ja) | 2020-10-14 |
Family
ID=57004251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017541855A Expired - Fee Related JP6769000B2 (ja) | 2015-04-03 | 2016-03-28 | ４’−チオヌクレオシドの新規な化合物、並びにその調製方法、その医薬組成物及びその用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10662214B2 (show.php) |
| EP (1) | EP3279207B1 (show.php) |
| JP (1) | JP6769000B2 (show.php) |
| CN (2) | CN106661077B (show.php) |
| AU (1) | AU2016240117C1 (show.php) |
| CA (1) | CA2975990A1 (show.php) |
| EA (1) | EA034375B1 (show.php) |
| WO (1) | WO2016155593A1 (show.php) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2865742C (en) | 2012-03-28 | 2017-04-18 | Fujifilm Corporation | Salt of 1-(2-deoxy-2-fluoro-4-thio-.beta.-d-arabinofuranosyl)cytosine |
| HRP20190572T1 (hr) | 2012-08-13 | 2019-05-17 | Fujifilm Corporation | POSREDNIK ZA SINTEZU 1-(2-DEOKSI-2 FLUORO-4-TIO-beta-D-ARABINOFURANOZIL) CITOZINA, POSREDNIK ZA SINTEZU TIONUKLEOZIDA, I METODE ZA PROIZVODNJU OVIH POSREDNIKA |
| TWI678373B (zh) * | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| CA2975990A1 (en) * | 2015-04-03 | 2016-10-06 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof |
| EP3508205B1 (en) | 2016-08-31 | 2022-05-18 | FUJIFILM Corporation | Anti-tumor agent, anti-tumor effect enhancer, and anti-tumor kit |
| CA3041420A1 (en) * | 2016-12-22 | 2018-06-28 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Solid form of 4'-thio-2'-fluoronucleoside phosphamide compound and preparation method therefor and use thereof |
| CN110573521B (zh) * | 2017-06-29 | 2023-04-21 | 四川科伦博泰生物医药股份有限公司 | 4’-硫代核苷的新型化合物的制备方法和此制备方法中的中间体 |
| EP3677267A4 (en) * | 2017-09-01 | 2021-06-02 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF TUMORS, METHOD AND USES THEREOF |
| AU2018404329B2 (en) | 2018-01-29 | 2021-09-09 | Fujifilm Corporation | Antitumor agent for biliary tract cancer and method for treating biliary tract cancer |
| KR102810546B1 (ko) * | 2018-04-19 | 2025-05-20 | 써던 리서취 인스티튜트 | 암의 치료를 위한 4'-티오-뉴클레오타이드 및 -뉴클레오사이드 전구약물 |
| CN112770731A (zh) * | 2018-11-28 | 2021-05-07 | 四川科伦博泰生物医药股份有限公司 | 以4’-硫代核苷类化合物为活性成分的口服药物组合物、其制备方法及其用途 |
| CN114341149A (zh) * | 2019-07-30 | 2022-04-12 | 匹诺生物股份有限公司 | 用于治疗癌症的二核苷酸化合物及其医学用途 |
| US12208112B2 (en) | 2020-04-23 | 2025-01-28 | Southern Research Institute | Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128458A (en) | 1990-04-20 | 1992-07-07 | Southern Research Institute | 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| WO1997038001A1 (en) * | 1996-04-09 | 1997-10-16 | Yamasa Corporation | 1-(2-DEOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINES |
| JPH1087687A (ja) * | 1996-04-09 | 1998-04-07 | Yamasa Shoyu Co Ltd | ５−置換−１−（２−デオキシ−２−フルオロ−４−チオ−β−Ｄ−アラビノフラノシル）ウラシル |
| GB0317009D0 (en) * | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
| AU2004274021B2 (en) | 2003-09-18 | 2009-08-13 | Isis Pharmaceuticals, Inc. | 4'-thionucleosides and oligomeric compounds |
| WO2007056596A2 (en) * | 2005-11-09 | 2007-05-18 | Wayne State University | Phosphoramidate derivatives of fau |
| GB201016855D0 (en) * | 2010-10-06 | 2010-11-17 | Nucana Biomed Ltd | Chemical compounds |
| WO2013013009A2 (en) * | 2011-07-19 | 2013-01-24 | Nanjing Molecular Research, Inc. | 2',3'-DIDEOXY-2'-α-FLUORO-2'-β-C-METHYLNUCLEOSIDES AND PRODRUGS THEREOF |
| WO2014124430A1 (en) * | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| US10005779B2 (en) * | 2013-06-05 | 2018-06-26 | Idenix Pharmaceuticals Llc | 1′,4′-thio nucleosides for the treatment of HCV |
| TWI678373B (zh) * | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| CA2975990A1 (en) * | 2015-04-03 | 2016-10-06 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof |
-
2016
- 2016-03-28 CA CA2975990A patent/CA2975990A1/en not_active Abandoned
- 2016-03-28 CN CN201680001812.5A patent/CN106661077B/zh active Active
- 2016-03-28 JP JP2017541855A patent/JP6769000B2/ja not_active Expired - Fee Related
- 2016-03-28 CN CN201811577363.6A patent/CN109553651B/zh active Active
- 2016-03-28 WO PCT/CN2016/077519 patent/WO2016155593A1/zh not_active Ceased
- 2016-03-28 EA EA201791535A patent/EA034375B1/ru unknown
- 2016-03-28 EP EP16771348.6A patent/EP3279207B1/en active Active
- 2016-03-28 AU AU2016240117A patent/AU2016240117C1/en not_active Ceased
- 2016-03-28 US US15/558,620 patent/US10662214B2/en active Active
-
2020
- 2020-04-17 US US16/851,217 patent/US20200262860A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513832A5 (show.php) | ||
| ES2925564T3 (es) | Derivados de azetidina tal como moduladores de receptores de quimiocinas y usos de los mismos | |
| JP5271913B2 (ja) | 化合物 | |
| KR101612642B1 (ko) | 테노포비어 알라펜아미드 헤미푸마레이트 | |
| ES2654161T3 (es) | Compuestos químicos | |
| JP2020515610A5 (show.php) | ||
| RU2007124329A (ru) | ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ | |
| CA2938280A1 (en) | 4-amino-imidazoquinoline compounds | |
| JP2013010792A5 (show.php) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| KR101986272B1 (ko) | 삼환식 화합물, 이를 포함하는 조성물 및 그의 용도 | |
| JP2013056886A5 (show.php) | ||
| KR20150046315A (ko) | 테노포비르 전구약물 및 그의 약학적 용도 | |
| ES2714100T3 (es) | Compuestos de quinolina fusionados como inhibidores de mTor, pi3k | |
| JP2015508092A5 (show.php) | ||
| JP2017534657A (ja) | 新型シチジン誘導体およびその適用 | |
| JP2020516616A5 (show.php) | ||
| CN105518012B (zh) | 一种取代的氨基酸硫酯类化合物、其组合物及应用 | |
| JP2015502371A5 (show.php) | ||
| RU2701728C2 (ru) | Новая поликристаллическая форма пролекарства тенофовира и способ ее получения и ее применение | |
| TWI638825B (zh) | 抑制癌症及病毒之化合物 | |
| JP6184866B2 (ja) | 新規抗がん剤 | |
| CA2552855A1 (en) | Azabicyclooctan-3-one derivatives and use thereof | |
| RU2008112181A (ru) | Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3 | |
| JP2013525290A5 (show.php) |